|

68Ga-R10602 injection Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Radionetics Oncology1

Indications

  • Metastatic Hormone Receptor Positive Breast Cancer1
  • Locoregionally Recurrent Hormone-receptor Positive Breast Cancer1
  • Hormone Receptor Positive Breast Adenocarcinoma1
  • Breast Cancer1
  • Cancer1

Los Angeles, California1 trial

Study of 68Ga-R10602

UCLA Department of Medicine - Hematology/Oncology

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.